Krebs Historical Income Statement

KREBSBIO   104.14  8.79  7.78%   
Historical analysis of Krebs Biochemicals income statement accounts such as Total Revenue of 274.5 M can show how well Krebs Biochemicals and performed in making a profits. Evaluating Krebs Biochemicals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Krebs Biochemicals's future profits or losses.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Krebs Biochemicals and latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Krebs Biochemicals and is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krebs Biochemicals and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Krebs Income Statement Analysis

Krebs Biochemicals and Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Krebs Biochemicals shareholders. The income statement also shows Krebs investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Krebs Biochemicals Income Statement Chart

As of now, Krebs Biochemicals' Income Tax Expense is increasing as compared to previous years. The Krebs Biochemicals' current Selling And Marketing Expenses is estimated to increase to about 48.5 M, while Depreciation And Amortization is projected to decrease to under 51.5 M.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Krebs Biochemicals and. It is also known as Krebs Biochemicals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Krebs Biochemicals and operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Krebs Biochemicals and is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Krebs Biochemicals and income statement and represents the costs associated with goods and services Krebs Biochemicals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.
Most accounts from Krebs Biochemicals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Krebs Biochemicals and current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krebs Biochemicals and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
As of now, Krebs Biochemicals' Income Tax Expense is increasing as compared to previous years. The Krebs Biochemicals' current Selling And Marketing Expenses is estimated to increase to about 48.5 M, while Depreciation And Amortization is projected to decrease to under 51.5 M.
 2021 2022 2023 2024 (projected)
Total Operating Expenses195.1M488.0M46.2M43.8M
Cost Of Revenue737M256.8M613.0M342.2M

Krebs Biochemicals income statement Correlations

0.630.620.740.60.57-0.190.080.310.380.58-0.09-0.23-0.04-0.140.160.26-0.38-0.130.290.11
0.630.440.770.250.69-0.39-0.140.030.630.38-0.44-0.42-0.4-0.150.01-0.20.310.31-0.410.09
0.620.440.540.630.38-0.060.160.30.160.560.02-0.060.07-0.39-0.10.38-0.3-0.290.24-0.23
0.740.770.540.360.94-0.53-0.35-0.160.80.65-0.55-0.49-0.510.170.34-0.260.080.46-0.210.5
0.60.250.630.360.120.250.450.56-0.270.760.340.320.38-0.190.070.56-0.29-0.460.63-0.24
0.570.690.380.940.12-0.77-0.64-0.470.890.6-0.79-0.64-0.760.290.36-0.550.170.64-0.370.64
-0.19-0.39-0.06-0.530.25-0.770.940.85-0.72-0.410.970.790.96-0.13-0.040.83-0.11-0.60.42-0.54
0.08-0.140.16-0.350.45-0.640.940.97-0.65-0.240.950.70.96-0.29-0.110.92-0.21-0.710.5-0.62
0.310.030.3-0.160.56-0.470.850.97-0.53-0.10.870.630.9-0.28-0.030.93-0.26-0.690.53-0.56
0.380.630.160.8-0.270.89-0.72-0.65-0.530.19-0.79-0.72-0.770.290.28-0.630.260.77-0.630.66
0.580.380.560.650.760.6-0.41-0.24-0.10.19-0.32-0.16-0.29-0.010.13-0.06-0.150.020.310.19
-0.09-0.440.02-0.550.34-0.790.970.950.87-0.79-0.320.771.0-0.24-0.110.91-0.31-0.760.59-0.6
-0.23-0.42-0.06-0.490.32-0.640.790.70.63-0.72-0.160.770.770.070.140.660.12-0.540.39-0.4
-0.04-0.40.07-0.510.38-0.760.960.960.9-0.77-0.291.00.77-0.26-0.120.93-0.33-0.770.6-0.61
-0.14-0.15-0.390.17-0.190.29-0.13-0.29-0.280.29-0.01-0.240.07-0.260.92-0.390.330.54-0.120.84
0.160.01-0.10.340.070.36-0.04-0.11-0.030.280.13-0.110.14-0.120.92-0.160.170.350.080.78
0.26-0.20.38-0.260.56-0.550.830.920.93-0.63-0.060.910.660.93-0.39-0.16-0.44-0.820.65-0.65
-0.380.31-0.30.08-0.290.17-0.11-0.21-0.260.26-0.15-0.310.12-0.330.330.17-0.440.58-0.730.18
-0.130.31-0.290.46-0.460.64-0.6-0.71-0.690.770.02-0.76-0.54-0.770.540.35-0.820.58-0.740.71
0.29-0.410.24-0.210.63-0.370.420.50.53-0.630.310.590.390.6-0.120.080.65-0.73-0.74-0.22
0.110.09-0.230.5-0.240.64-0.54-0.62-0.560.660.19-0.6-0.4-0.610.840.78-0.650.180.71-0.22
Click cells to compare fundamentals

Krebs Biochemicals Account Relationship Matchups

Krebs Biochemicals income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization46.8M51.2M63.0M65.6M67.7M51.5M
Interest Expense60.0M62.8M54.4M29.7M46.9M41.6M
Selling General Administrative8.4M6.7M11.2M8.6M6.0M5.7M
Total Revenue235.8M386.1M529.4M521.3M504.2M274.5M
Gross Profit(93.3M)(136.3M)(207.6M)264.6M(108.7M)(103.3M)
Other Operating Expenses476.1M613.1M932.1M744.7M659.1M520.4M
Operating Income(240.3M)(227.0M)(402.9M)(217.2M)(152.0M)(159.6M)
Ebit(227.5M)(220.8M)(391.4M)(217.2M)(150.4M)(157.9M)
Ebitda(180.7M)(169.6M)(328.4M)(151.6M)(82.7M)(86.9M)
Cost Of Revenue329.1M522.3M737M256.8M613.0M342.2M
Total Operating Expenses147.0M90.8M195.1M488.0M46.2M43.8M
Income Before Tax(288.7M)(283.6M)(445.3M)(246.9M)(197.3M)(207.1M)
Total Other Income Expense Net(48.5M)(111.2M)(424.9M)(27.5M)(45.3M)(47.6M)
Net Income(288.7M)(283.6M)(445.3M)(246.9M)(197.3M)(207.1M)
Income Tax Expense12.7M6.2M13.9M65.4M67.5M70.9M
Selling And Marketing Expenses976K47K38K40.2M46.2M48.5M
Net Income From Continuing Ops(288.7M)(283.6M)(445.3M)(246.9M)(197.3M)(207.1M)
Net Income Applicable To Common Shares(288.7M)(283.6M)(445.3M)(246.9M)(222.2M)(233.3M)
Interest Income51.5M62.8M3.6M29.7M34.2M40.7M
Research Development9.7M14.7M16.4M11.3M12.7M11.1M
Net Interest Income(57.4M)(62.8M)(53.9M)(29.7M)(46.9M)(49.2M)
Reconciled Depreciation46.8M51.2M63.0M65.6M67.7M59.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Krebs Stock

Krebs Biochemicals and Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Krebs Biochemicals shareholders. The income statement also shows Krebs investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).